跳至主要内容
临床试验/NCT03069404
NCT03069404已完成不适用

INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI, an Investigator Initiated Trial

University of Zurich1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
American Spinal Injury Association (ASIA) Impairment Scale Improvement

研究概览

简要总结

The investigation is a multi-year observational study following the completion of the open-label, single dose Phase I/II study involving transplantation of allogeneic HuCNS-SC cells into 12 subjects with thoracic spinal cord injury.

Subjects will be monitored at routine intervals for safety and preliminary efficacy for 5 years post-transplantation of the Phase I/II investigation CL-N02-SC.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Must have undergone HuCNS-SC transplantation as a subject in the Phase I/II trial
  • Must be able to provide written informed consent prior to any study related procedures
  • Must agree to comply in good faith with all conditions of the study and to attend all required study visits
  • Female subjects who are pregnant remain eligible for enrollment, but the MRI examination will not be performed during the pregnancy. Female subjects of child-bearing potential must have a negative urine pregnancy test prior to the MRI examination

排除标准

  • Subjects have received or are receiving off-protocol immunosuppressive medications
  • Subjects who after completion of CL-N02-SC have entered, or are about to enter any other interventional study

结局指标

主要结局

American Spinal Injury Association (ASIA) Impairment Scale Improvement

时间窗: 36 months after transplantation of HuCNS-SC®

Evidence of improvement in ASIA impairment scale as confirmed by neurological examination

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

INSTrUCT-SCI: INdependent Observational STUdy of... | 临床试验